rs10771399: Understanding This Breast Cancer Susceptibility Variant
The genetic variant rs10771399 is a single nucleotide polymorphism located at the 12p11 chromosomal locus. Research has identified this variant as a susceptibility marker associated with breast cancer risk in both estrogen receptor-positive and estrogen receptor-negative cases.
What each genotype means
Baseline breast cancer risk
This genotype represents the common state at this locus. Research indicates that carrying this genotype is associated with a standard level of breast cancer susceptibility compared to those carrying the G allele, which has been linked to a protective effect in some studies.
This is a common genotype found across diverse global populations.
Slightly altered cancer risk
Individuals with this genotype carry one copy of the G allele, which has been associated with a modest reduction in breast cancer risk in both European and Chinese populations. This association has also been observed in BRCA1 mutation carriers, particularly regarding estrogen receptor-negative breast cancer risk.
This heterozygous genotype is frequently observed, with the minor allele frequency for this variant ranging between 0.11 and 0.41 depending on ancestry.
Potential protective risk profile
Carrying two copies of the G allele is associated with a statistically significant reduction in breast cancer risk compared to the AA genotype. While this variant is linked to susceptibility, it is important to remember that genetic risk is only one factor in overall health; please discuss any concerns regarding cancer screening or family history with your clinician.
This genotype is less common than the others, reflecting the distribution of the minor allele across various ancestral groups.
What is rs10771399?
The variant rs10771399 is a specific change in the DNA sequence located in an intergenic region on chromosome 12, specifically at the 12p11 locus. In genetics, an intergenic region refers to the stretch of DNA that lies between genes. While this variant does not sit within a protein-coding gene, it is often studied in the context of its proximity to nearby genes, such as PTHLH. Scientists use genome-wide association studies (GWAS) to identify such markers by comparing the DNA of individuals with a specific condition to those without it. When a particular variant appears more frequently in one group, it is flagged as being statistically associated with that trait or disease. rs10771399 has been identified through these large-scale studies as a marker of interest for breast cancer susceptibility.
Research and Evidence
The evidence linking rs10771399 to breast cancer is considered moderate and has been replicated across various studies. Research indicates that this variant is associated with breast cancer risk in both estrogen receptor (ER)-positive and ER-negative cases. Notably, some studies have highlighted its relevance for BRCA1 mutation carriers, where the variant showed a specific association with ER-negative breast cancer risk. While the statistical association is robust in large cohorts, it is important to understand that this variant is just one of many genetic factors that contribute to overall breast cancer risk. The biological mechanism by which this intergenic variant influences cancer susceptibility is still a subject of ongoing investigation, as it may involve the regulation of nearby genes rather than a direct change to a protein's structure.
Population Frequency
The frequency of the alleles at the rs10771399 locus varies across different ancestral populations. The minor allele frequency for this variant is reported to range between 0.11 and 0.41. This variation means that the prevalence of the different genotypes (the specific pair of alleles an individual carries) differs significantly depending on one's genetic background. Because these frequencies are not uniform globally, the impact of this variant on population-level risk can also differ. Researchers account for these differences by adjusting for population stratification in their studies to ensure that the observed associations are genuine and not simply a result of ancestral differences between the case and control groups being analyzed.
Interpreting Genetic Information
It is essential to view genetic information like rs10771399 in the proper context. Having a specific genotype at this locus does not mean an individual will or will not develop breast cancer; rather, it represents a small shift in statistical risk. Breast cancer is a complex, multifactorial condition influenced by a combination of genetics, lifestyle, and environmental factors. Genetic testing for such variants is not a diagnostic tool and should not be used to predict individual health outcomes in isolation. If you have concerns about your personal or family history of breast cancer, the most appropriate step is to consult with a healthcare professional or a genetic counselor. They can provide personalized guidance based on your full clinical picture, which is far more informative than looking at a single genetic variant.
How common is this variant?
The minor allele frequency for rs10771399 ranges from 0.11 to 0.41 across different global populations, indicating that the variant is relatively common.
Frequently asked questions
Does having the rs10771399 variant mean I will get breast cancer?
No. This variant is associated with a statistical change in risk, not a certainty of disease. Many other genetic and environmental factors play a much larger role in determining breast cancer risk.
Should I get tested for rs10771399?
Genetic testing for common susceptibility variants is generally not recommended for individual clinical decision-making. You should discuss your family history and any concerns with a doctor or genetic counselor.
Is rs10771399 the same as a BRCA mutation?
No. BRCA1 and BRCA2 mutations are rare, high-penetrance variants that significantly increase breast cancer risk. rs10771399 is a common variant with a much smaller effect on risk.
Where can I find more information on breast cancer genetics?
MedlinePlus Genetics is an excellent resource for learning about the genetic basis of various conditions. You can also look for information provided by major health organizations like the American Cancer Society.
Sources & further reading
Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10771399?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant at the 12q24 locus is associated with an increased risk of estrogen receptor-positive breast cancer.
This variant at the 21q21 locus is associated with an increased risk of estrogen receptor-positive breast cancer.
This variant is associated with systemic lupus erythematosus susceptibility and has been investigated for its role in neurodevelopmental regulation.
This missense variant in the KIT gene is associated with gastrointestinal stromal tumors and potential sensitivity to imatinib therapy.
The AA genotype of this splicing factor gene variant is associated with an increased predisposition to systemic sclerosis.
This variant in the MUT gene is linked to methylmalonic acidemia and is frequently annotated in clinical variant databases.